title: Abortion.
mesh_terms: D000028:Abortion, Induced; D000554:Ambulatory Care Facilities; D000569:Americas; D001695:Biology; D003257:Consumer Product Safety; D003695:Delivery of Health Care; D019049:Developed Countries; D004467:Economics; D004703:Endocrine System; D005321:Extraembryonic Membranes; D005193:Family Planning Services; D005333:Fetus; D005376:Financial Management; D005380:Financing, Government; D006262:Health; D006268:Health Facilities; D006727:Hormone Antagonists; D006728:Hormones; D006806:Human Rights; D007206:Individuality; D007258:Informed Consent; D007348:Insurance, Health; D007878:Legislation as Topic; D008004:Licensure; D015735:Mifepristone; D009656:North America; D010827:Physiology; D011247:Pregnancy; D012098:Reproduction; D012106:Research; D020458:Third-Party Consent; D014481:United States
chemical_list: D006727:Hormone Antagonists; D006728:Hormones; D015735:Mifepristone
keywords: Abortion Centers--legal aspects; Abortion Law; Abortion, Induced; Americas; Biology; Delivery Of Health Care; Developed Countries; Economic Factors; Endocrine System; Family Planning; Fertility Control, Postconception; Fetal Membranes; Fetal Tissue--legal aspects; Fetus; Financial Activities; Financing, Government; Funds; Health; Health Facilities; Health Insurance--legal aspects; Hormone Antagonists; Hormones; Human Rights--women; Informed Consent--legal aspects; Laws And Statutes; Legislation; Licensing; North America; Northern America; Parental Consent--legal aspects; Personhood; Physiology; Pregnancy; Product Approval; Reproduction; Research Activities; Research Methodology; Ru-486--legal aspects; United States